Filing Flows › Zevra Therapeutics (ZVRA) › Net income
Zevra Therapeutics (ZVRA) net income by quarter
Zevra Therapeutics' net income was $19.2M in Q3 2026 (third quarter 2026), +119% from Q2 2026. Over the last 4 quarters it ranged from $8.8M (Q2 2026) to $37.9M (Q1 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $19.2M | +119% | — |
| Q2 2026 | $8.8M | -77% | — |
| Q1 2026 | $37.9M | +211% | — |
| Q4 2025 | $12.2M | — | — |
Q3 2026 at a glance
Zevra Therapeutics, Q3 2026: revenue $37.8M (+45% year over year), operating margin 30.7%, net earnings $19.2M, operating cash flow $10.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Zevra Therapeutics' net income?
Zevra Therapeutics' net income was $19.2M in Q3 2026 (third quarter 2026), +119% from Q2 2026.
How has Zevra Therapeutics' net income changed?
Over the last 4 quarters it ranged from $8.8M (Q2 2026) to $37.9M (Q1 2026).